STOCK TITAN

Whitehawk CTO awarded 91,633 options, RSUs

(Neutral)
(Neutral)
Form Type
4/A

Rhea-AI Filing Summary

Whitehawk Therapeutics, Inc. (WHWK) reported that Chief Technical Operations Officer Bryan Ball received two equity awards on September 15, 2026: a stock option covering 91,633 shares of common stock with an exercise price of $4.09 per share, and an award of 91,633 restricted stock units, each representing one share of common stock.

The stock option vests over four years, with 25% of the shares vesting on the one-year anniversary of the Vesting Commencement Date of September 15, 2026, and the remainder vesting in equal monthly installments so that all shares are vested by the four-year anniversary. The restricted stock unit award vests 100% on the one-year anniversary of the same Vesting Commencement Date, assuming Mr. Ball continues as a service provider. The amended filing corrects an earlier Form 4 that had reported an incorrect vesting schedule for the restricted stock units. No transactions were made under a Rule 10b5-1 trading plan.

Positive

  • None.

Negative

  • None.
Insider BALL BRYAN
Role See remarks
Type Security Shares Price Value
Grant/Award Stock Option (right to buy) F1 91,633 $0.00 $0.00
Grant/Award Restricted Stock Units F2, F3 91,633 $0.00 $0.00
Holdings After Transaction: Stock Option (right to buy) — 91,633 contracts (Direct); Restricted Stock Units — 91,633 contracts (Direct)
Footnotes (3)
  1. F1. Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through each applicable date, twenty five percent (25%) of the shares subject to the option shall vest on the one-year anniversary of the Vesting Commencement Date and 1/48th of the total shares subject to the option shall vest every month thereafter such that all shares subject to the option shall be fully vested on the four-year anniversary of the Vesting Commencement Date. "Vesting Commencement Date" shall mean September 15, 2026.
  2. F2. Each restricted stock unit ("RSU") represents a contingent right to receive one share of Whitehawk Therapeutics, Inc. Common Stock.
  3. F3. The original Form 4 filed by the Reporting Person erroneously reflected an incorrect vesting schedule. Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through the applicable date, one hundred percent (100%) of the shares subject to the award shall vest on the one-year anniversary of the Vesting Commencement Date. "Vesting Commencement Date" shall mean September 15, 2026.
Stock options granted 91,633 options Grant to Chief Technical Operations Officer on September 15, 2026
RSUs granted 91,633 restricted stock units Grant to Chief Technical Operations Officer on September 15, 2026
Option exercise price $4.09 per share Exercise price of stock option covering 91,633 shares
Initial option vesting portion 25% Portion of option shares vesting on the one-year anniversary of the Vesting Commencement Date
Ongoing monthly option vesting 1/48 of total shares per month Monthly vesting of remaining option shares after the first anniversary
RSU cliff vesting 100% after one year All RSU shares vest on the one-year anniversary of the Vesting Commencement Date
Vesting Commencement Date September 15, 2026 Starting point used to determine vesting anniversaries for both awards
Option expiration September 15, 2036 Expiration date of the stock option grant
Restricted Stock Units financial
"Each restricted stock unit ("RSU") represents a contingent right to receive one share"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
Vesting Commencement Date financial
""Vesting Commencement Date" shall mean September 15, 2026."
The vesting commencement date is the starting point when an employee begins earning ownership rights to their promised benefits, such as stock options or retirement contributions. Think of it like the day a savings account is opened—only after this date do the benefits start to grow and become fully available over time. It matters to investors because it marks when the clock begins ticking toward full ownership, affecting the timing and value of these benefits.
Service Provider financial
"Subject to the Reporting Person continuing to be a Service Provider"
Equity Incentive Plan financial
"as defined in the Issuer's 2021 Equity Incentive Plan"
An equity incentive plan is a program that gives employees, executives or directors the right to receive company stock or options to buy stock as part of their pay. Think of it as offering slices of future company profit to motivate people to boost long‑term performance; for investors it matters because it can align employee goals with shareholder value but also increases the number of shares outstanding, which can dilute existing ownership.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What equity awards did WHWK grant to Bryan Ball in this amended Form 4?

Bryan Ball received a stock option for 91,633 shares of Whitehawk Therapeutics common stock at $4.09 per share and a separate award of 91,633 restricted stock units, each RSU representing a contingent right to receive one share of common stock.

How do the stock options granted to the WHWK officer vest?

The stock option vests over four years. 25% of the shares vest on the one-year anniversary of the September 15, 2026 Vesting Commencement Date, and 1/48 of the total shares vest each month thereafter, so all shares are vested by the four-year anniversary.

What is the vesting schedule for the WHWK restricted stock units granted?

The restricted stock units vest 100% on the one-year anniversary of the Vesting Commencement Date of September 15, 2026, provided Bryan Ball continues to be a service provider under Whitehawk Therapeutics’ 2021 Equity Incentive Plan through that vesting date.

What correction does this amended Form 4/A for WHWK make?

The amendment states that the original Form 4 filed by Bryan Ball erroneously reflected an incorrect vesting schedule for the restricted stock units and clarifies that all RSUs vest 100% on the one-year anniversary of the Vesting Commencement Date.

Were Bryan Ball’s WHWK equity awards granted under a Rule 10b5-1 trading plan?

No. The filing indicates that the Rule 10b5-1 checkbox is not marked, so the reported awards were not made under a Rule 10b5-1 trading plan; they are compensation-related grants rather than pre-arranged trading plan transactions.

How many WHWK shares does Bryan Ball hold from these new awards after the transactions?

Following the reported transactions, Bryan Ball holds 91,633 stock options and 91,633 restricted stock units relating to Whitehawk Therapeutics common stock, each award reported as a new position with that full amount after the grant on September 15, 2026.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
BALL BRYAN

(Last)(First)(Middle)
C/O WHITEHAWK THERAPEUTICS, INC.
2 HEADQUARTERS PLAZA, EAST BUILDING, 11T

(Street)
MORRISTOWN NEW JERSEY 07960

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
Whitehawk Therapeutics, Inc. [ WHWK ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director10% Owner
XOfficer (give title below)Other (specify below)
See remarks
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
09/15/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)
09/15/2026
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Stock Option (right to buy)$4.0909/15/2026A91,633 (1)09/15/2036Common Stock91,633$091,633D
Restricted Stock Units(2)09/15/2026A91,633 (3) (3)Common Stock91,633$091,633D
Explanation of Responses:
1. Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through each applicable date, twenty five percent (25%) of the shares subject to the option shall vest on the one-year anniversary of the Vesting Commencement Date and 1/48th of the total shares subject to the option shall vest every month thereafter such that all shares subject to the option shall be fully vested on the four-year anniversary of the Vesting Commencement Date. "Vesting Commencement Date" shall mean September 15, 2026.
2. Each restricted stock unit ("RSU") represents a contingent right to receive one share of Whitehawk Therapeutics, Inc. Common Stock.
3. The original Form 4 filed by the Reporting Person erroneously reflected an incorrect vesting schedule. Subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2021 Equity Incentive Plan) through the applicable date, one hundred percent (100%) of the shares subject to the award shall vest on the one-year anniversary of the Vesting Commencement Date. "Vesting Commencement Date" shall mean September 15, 2026.
Remarks:
Chief Technical Operations Officer
/s/ Stephen Rodin, as Attorney-in-Fact09/18/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Keep reading